315 related articles for article (PubMed ID: 34811514)
21. CYCLINg through transcription: posttranslational modifications of P-TEFb regulate transcription elongation.
Cho S; Schroeder S; Ott M
Cell Cycle; 2010 May; 9(9):1697-705. PubMed ID: 20436276
[TBL] [Abstract][Full Text] [Related]
22. Acetylation of conserved lysines in the catalytic core of cyclin-dependent kinase 9 inhibits kinase activity and regulates transcription.
Sabò A; Lusic M; Cereseto A; Giacca M
Mol Cell Biol; 2008 Apr; 28(7):2201-12. PubMed ID: 18250157
[TBL] [Abstract][Full Text] [Related]
23. Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes.
Schröder S; Cho S; Zeng L; Zhang Q; Kaehlcke K; Mak L; Lau J; Bisgrove D; Schnölzer M; Verdin E; Zhou MM; Ott M
J Biol Chem; 2012 Jan; 287(2):1090-9. PubMed ID: 22084242
[TBL] [Abstract][Full Text] [Related]
24. Requirement for a kinase-specific chaperone pathway in the production of a Cdk9/cyclin T1 heterodimer responsible for P-TEFb-mediated tat stimulation of HIV-1 transcription.
O'Keeffe B; Fong Y; Chen D; Zhou S; Zhou Q
J Biol Chem; 2000 Jan; 275(1):279-87. PubMed ID: 10617616
[TBL] [Abstract][Full Text] [Related]
25. A single point mutation in cyclin T1 eliminates binding to Hexim1, Cdk9 and RNA but not to AFF4 and enforces repression of HIV transcription.
Kuzmina A; Verstraete N; Galker S; Maatook M; Bensaude O; Taube R
Retrovirology; 2014 Jul; 11():51. PubMed ID: 24985467
[TBL] [Abstract][Full Text] [Related]
26. Characterization of Cdk9 T-loop phosphorylation in resting and activated CD4(+) T lymphocytes.
Ramakrishnan R; Dow EC; Rice AP
J Leukoc Biol; 2009 Dec; 86(6):1345-50. PubMed ID: 19741158
[TBL] [Abstract][Full Text] [Related]
27. Cyclin-dependent kinase 9 (Cdk9) of fission yeast is activated by the CDK-activating kinase Csk1, overlaps functionally with the TFIIH-associated kinase Mcs6, and associates with the mRNA cap methyltransferase Pcm1 in vivo.
Pei Y; Du H; Singer J; Stamour C; Granitto S; Shuman S; Fisher RP
Mol Cell Biol; 2006 Feb; 26(3):777-88. PubMed ID: 16428435
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel CDK9 inhibitor targeting the intramolecular hidden cavity of CDK9 induced by Tat binding.
Asamitsu K; Hirokawa T; Okamoto T
PLoS One; 2022; 17(11):e0277024. PubMed ID: 36378653
[TBL] [Abstract][Full Text] [Related]
29. Short communication: SAHA (vorinostat) induces CDK9 Thr-186 (T-loop) phosphorylation in resting CD4+ T cells: implications for reactivation of latent HIV.
Ramakrishnan R; Liu H; Rice AP
AIDS Res Hum Retroviruses; 2015 Jan; 31(1):137-41. PubMed ID: 24528253
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms controlling CDK9 activity.
Marshall RM; Grana X
Front Biosci; 2006 Sep; 11():2598-613. PubMed ID: 16720337
[TBL] [Abstract][Full Text] [Related]
31. Transcription Elongation Factor P-TEFb Is Involved in IL-17F Signaling in Airway Smooth Muscle Cells.
Nakajima M; Kawaguchi M; Matsuyama M; Ota K; Fujita J; Matsukura S; Huang SK; Morishima Y; Ishii Y; Satoh H; Sakamoto T; Hizawa N
Int Arch Allergy Immunol; 2018; 176(2):83-90. PubMed ID: 29649811
[TBL] [Abstract][Full Text] [Related]
32. CDK9 keeps RNA polymerase II on track.
Egloff S
Cell Mol Life Sci; 2021 Jul; 78(14):5543-5567. PubMed ID: 34146121
[TBL] [Abstract][Full Text] [Related]
33. G-actin participates in RNA polymerase II-dependent transcription elongation by recruiting positive transcription elongation factor b (P-TEFb).
Qi T; Tang W; Wang L; Zhai L; Guo L; Zeng X
J Biol Chem; 2011 Apr; 286(17):15171-81. PubMed ID: 21378166
[TBL] [Abstract][Full Text] [Related]
34. P-TEFb goes viral.
Zaborowska J; Isa NF; Murphy S
Bioessays; 2016 Jul; 38 Suppl 1():S75-85. PubMed ID: 27417125
[TBL] [Abstract][Full Text] [Related]
35. Recruitment of cyclin-dependent kinase 9 to nuclear compartments during cytomegalovirus late replication: importance of an interaction between viral pUL69 and cyclin T1.
Feichtinger S; Stamminger T; Müller R; Graf L; Klebl B; Eickhoff J; Marschall M
J Gen Virol; 2011 Jul; 92(Pt 7):1519-1531. PubMed ID: 21450947
[TBL] [Abstract][Full Text] [Related]
36. The structure of P-TEFb (CDK9/cyclin T1), its complex with flavopiridol and regulation by phosphorylation.
Baumli S; Lolli G; Lowe ED; Troiani S; Rusconi L; Bullock AN; Debreczeni JE; Knapp S; Johnson LN
EMBO J; 2008 Jul; 27(13):1907-18. PubMed ID: 18566585
[TBL] [Abstract][Full Text] [Related]
37. The Establishment of a Hyperactive Structure Allows the Tumour Suppressor Protein p53 to Function through P-TEFb during Limited CDK9 Kinase Inhibition.
Albert TK; Antrecht C; Kremmer E; Meisterernst M
PLoS One; 2016; 11(1):e0146648. PubMed ID: 26745862
[TBL] [Abstract][Full Text] [Related]
38. Discovery of Small-Molecule Degraders of the CDK9-Cyclin T1 Complex for Targeting Transcriptional Addiction in Prostate Cancer.
Li J; Liu T; Song Y; Wang M; Liu L; Zhu H; Li Q; Lin J; Jiang H; Chen K; Zhao K; Wang M; Zhou H; Lin H; Luo C
J Med Chem; 2022 Aug; 65(16):11034-11057. PubMed ID: 35925880
[TBL] [Abstract][Full Text] [Related]
39. Identification of novel CDK9 and Cyclin T1-associated protein complexes (CCAPs) whose siRNA depletion enhances HIV-1 Tat function.
Ramakrishnan R; Liu H; Donahue H; Malovannaya A; Qin J; Rice AP
Retrovirology; 2012 Oct; 9():90. PubMed ID: 23110726
[TBL] [Abstract][Full Text] [Related]
40. Effects of prostratin on Cyclin T1/P-TEFb function and the gene expression profile in primary resting CD4+ T cells.
Sung TL; Rice AP
Retrovirology; 2006 Oct; 3():66. PubMed ID: 17014716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
